Scinai Immunotherapeutics Ownership | Who Owns Scinai Immunotherapeutics?
Scinai Immunotherapeutics Ownership Summary
Scinai Immunotherapeutics is owned by 1.12% institutional investors, and 98.88% retail investors. Fidelity Nasdaq Composite Index is the top mutual fund, with 0.02% of its assets in Scinai Immunotherapeutics shares.
BVXV Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Scinai Immunotherapeutics | 1.12% | - | 98.88% |
Sector | Healthcare Stocks | 47.06% | 8.01% | 44.93% |
Industry | Biotech Stocks | 44.97% | 7.82% | 47.21% |
Institutional Shareholders
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Sep 30, 2022 | 10 | -23.08% | 209,678 | -37.19% | 1 | 35.12% | 3 | -25.00% | 3 | -25.00% |
Jun 30, 2022 | 13 | -23.53% | 333,826 | 1.10% | 1 | 33.31% | 4 | -63.64% | 4 | 300.00% |
Mar 31, 2022 | 17 | 30.77% | 330,182 | -1.77% | 2 | 40.84% | 11 | 57.14% | 1 | - |
Dec 31, 2021 | 13 | -13.33% | 336,148 | 31.98% | 2 | 75.40% | 7 | 16.67% | 1 | -66.67% |
Sep 30, 2021 | 15 | - | 254,693 | -18.18% | 1 | 37.67% | 6 | -25.00% | 3 | 200.00% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Fidelity Nasdaq Composite Index | 1.38K | 0.02% | - |
SPDR® Portfolio Developed Wld ex-US ETF | 2.00 | 0.00% | - |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2031 Q1 | - | - |
2025 Q1 | - | - |
2024 Q4 | - | - |
2023 Q1 | - | - |
BVXV Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools